IPO
Immix Biopharma, Inc.
Biopharmaceutical
We are a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics (“TSTx”)TM in oncology and inflammation.
Symbol
IMMX
Price Range
$5.00 - $6.00
Anticipated Date
December 16, 2021
Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Immix Biopharma, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277